Preclinical News and Research

RSS
Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Mesoblast cleared to begin first phase 2 clinical trial for wet AMD

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

Mesoblast receives Singapore HSA regulatory clearance to begin wet AMD Phase 2 trial

Two proteins bind together to ignite and sustain malignant brain tumors

Two proteins bind together to ignite and sustain malignant brain tumors

Xencor commences XmAb5871 Phase 1 trial in autoimmune diseases

Xencor commences XmAb5871 Phase 1 trial in autoimmune diseases

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Ipsen, Syntaxin collaborate to develop new botulinum toxins

Ipsen, Syntaxin collaborate to develop new botulinum toxins

Breakthrough in development of effective therapy against Hendra virus

Breakthrough in development of effective therapy against Hendra virus

JHU, Eisai enter drug-discovery research collaboration for brain disorders

JHU, Eisai enter drug-discovery research collaboration for brain disorders

SAIC receives NIAID contract to develop biopharmaceutical products for infectious diseases

SAIC receives NIAID contract to develop biopharmaceutical products for infectious diseases

Oral laquinimod shows promise against multiple sclerosis

Oral laquinimod shows promise against multiple sclerosis

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

FDA approves Oxford BioMedica's UshStat IND to treat Usher syndrome type 1B

TPP, University of Dundee sign collaboration agreement for drug development fund

TPP, University of Dundee sign collaboration agreement for drug development fund

VEGF protein appears to prevent progression of spinocerebellar ataxia type 1

VEGF protein appears to prevent progression of spinocerebellar ataxia type 1

NIH grants support SUNY's neuroscience, pediatric pharmacology and vision research

NIH grants support SUNY's neuroscience, pediatric pharmacology and vision research

Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme

Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme

Brain scans can evaluate new treatments for attention deficit disorder

Brain scans can evaluate new treatments for attention deficit disorder

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Janssen, BeiGene enter in-licensing agreement for two clinical-stage oncology compounds

Four companies receive NIAID contracts to develop broad-spectrum therapeutics

Four companies receive NIAID contracts to develop broad-spectrum therapeutics

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.